UroGen Pharma Ltd. Cost of Revenue in USD from 2016 to Q3 2025

Taxonomy & unit
us-gaap: USD
Description
The aggregate cost of goods produced and sold and services rendered during the reporting period.
Summary
UroGen Pharma Ltd. quarterly/annual Cost of Revenue history and growth rate from 2016 to Q3 2025.
  • UroGen Pharma Ltd. Cost of Revenue for the quarter ending September 30, 2025 was $3.28M, a 33.6% increase year-over-year.
  • UroGen Pharma Ltd. Cost of Revenue for the twelve months ending September 30, 2025 was $11.6M, a 33.7% increase year-over-year.
  • UroGen Pharma Ltd. annual Cost of Revenue for 2024 was $8.88M, a 5.13% decline from 2023.
  • UroGen Pharma Ltd. annual Cost of Revenue for 2023 was $9.36M, a 22.3% increase from 2022.
  • UroGen Pharma Ltd. annual Cost of Revenue for 2022 was $7.65M, a 48.4% increase from 2021.
Cost of Revenue, Trailing 12 Months (USD)
Cost of Revenue, Quarterly (USD)
Cost of Revenue, YoY Quarterly Growth (%)
Cost of Revenue, Annual (USD)
Cost of Revenue, YoY Annual Growth (%)

UroGen Pharma Ltd. Quarterly Cost of Revenue (USD)

Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q3 2025 $11.6M $3.28M +$825K +33.6% Jul 1, 2025 Sep 30, 2025 10-Q 2025-11-06
Q2 2025 $10.8M $3.55M +$1.32M +59.3% Apr 1, 2025 Jun 30, 2025 10-Q 2025-08-07
Q1 2025 $9.48M $2.33M +$602K +34.8% Jan 1, 2025 Mar 31, 2025 10-Q 2025-05-12
Q4 2024 $8.88M $2.47M +$185K +8.09% Oct 1, 2024 Dec 31, 2024 10-K 2025-03-10
Q3 2024 $8.7M $2.45M +$86K +3.63% Jul 1, 2024 Sep 30, 2024 10-Q 2025-11-06
Q2 2024 $8.61M $2.23M -$214K -8.76% Apr 1, 2024 Jun 30, 2024 10-Q 2025-08-07
Q1 2024 $8.82M $1.73M -$537K -23.7% Jan 1, 2024 Mar 31, 2024 10-Q 2025-05-12
Q4 2023 $9.36M $2.29M +$23K +1.02% Oct 1, 2023 Dec 31, 2023 10-K 2025-03-10
Q3 2023 $9.34M $2.37M +$347K +17.2% Jul 1, 2023 Sep 30, 2023 10-Q 2024-11-06
Q2 2023 $8.99M $2.44M +$597K +32.3% Apr 1, 2023 Jun 30, 2023 10-Q 2024-08-13
Q1 2023 $8.39M $2.27M +$740K +48.5% Jan 1, 2023 Mar 31, 2023 10-Q 2024-05-13
Q4 2022 $7.65M $2.26M +$674K +42.4% Oct 1, 2022 Dec 31, 2022 10-K 2024-03-14
Q3 2022 $6.98M $2.02M +$776K +62.4% Jul 1, 2022 Sep 30, 2022 10-Q 2023-11-14
Q2 2022 $6.2M $1.85M +$419K +29.4% Apr 1, 2022 Jun 30, 2022 10-Q 2023-08-10
Q1 2022 $5.79M $1.53M +$628K +70% Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-11
Q4 2021 $5.16M $1.59M Oct 1, 2021 Dec 31, 2021 10-K 2023-03-24
Q3 2021 $1.24M +$935K +303% Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-10
Q2 2021 $1.43M +$1.38M +2873% Apr 1, 2021 Jun 30, 2021 10-Q 2022-08-11
Q1 2021 $897K Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-10
Q3 2020 $309K Jul 1, 2020 Sep 30, 2020 10-Q 2021-11-15
Q2 2020 $48K Apr 1, 2020 Jun 30, 2020 10-Q 2021-08-04
Q4 2018 $1.8M $0 Oct 1, 2018 Dec 31, 2018 10-K 2020-03-02
Q3 2018 $1.06M +$760K +258% Jul 1, 2018 Sep 30, 2018 10-Q 2019-11-12
Q2 2018 $318K Apr 1, 2018 Jun 30, 2018 10-Q 2019-08-09
Q1 2018 $430K +$412K +2289% Jan 1, 2018 Mar 31, 2018 10-Q 2019-05-09
Q3 2017 $295K Jul 1, 2017 Sep 30, 2017 6-K 2018-11-13
Q1 2017 $18K Jan 1, 2017 Mar 31, 2017 6-K 2018-05-15

UroGen Pharma Ltd. Annual Cost of Revenue (USD)

Period Value YoY Chg Change % Start Date End Date Report Filed
2024 $8.88M -$480K -5.13% Jan 1, 2024 Dec 31, 2024 10-K 2025-03-10
2023 $9.36M +$1.71M +22.3% Jan 1, 2023 Dec 31, 2023 10-K 2025-03-10
2022 $7.65M +$2.5M +48.4% Jan 1, 2022 Dec 31, 2022 10-K 2024-03-14
2021 $5.16M +$4.15M +411% Jan 1, 2021 Dec 31, 2021 10-K 2023-03-24
2020 $1.01M Jan 1, 2020 Dec 31, 2020 10-K 2022-03-21
2018 $1.8M +$1.2M +201% Jan 1, 2018 Dec 31, 2018 10-K 2020-03-02
2017 $600K +$572K +2043% Jan 1, 2017 Dec 31, 2017 10-K 2020-03-02
2016 $28K Jan 1, 2016 Dec 31, 2016 10-K 2019-02-28
* An asterisk sign (*) next to the value indicates that the value is likely invalid.